Contact Us: (317) 621-2520

Curriculum Vitae

JEFFREY D. WAGNER, MD
Corporate President, Jeffrey D. Wagner MD, PC.
Wagner and Associates Plastic and Reconstructive Surgery Associates of Indiana

EDUCATION:

UNDERGRADUATE:
GUSTAVUS ADOLPHUS COLLEGE
St. Peter, MN 1978-82
DEGREE: B.A. in Biology

GRADUATE MEDICAL:
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Minneapolis, MN 1982-86
DEGREE: Doctor of Medicine, June 1986

POST-GRADUATE:
INTERNSHIP: UNIVERSITY OF WASHINGTON (General Surgery) 1986-87
RESIDENCY: UNIVERSITY OF WASHINGTON (General Surgery) 1987-91
CHIEF RESIDENT: UNIVERSITY OF WASHINGTON (General Surgery) 1990-91
PLASTIC SURGERY RESIDENCY: UNIVERSITY OF MICHIGAN 1991-93

ACADEMIC APPOINTMENTS:

  • Assistant Professor of Surgery, Indiana University School of Medicine, Department of Surgery July 1993 – 1999
  • Associate Professor of Surgery, Indiana University School of Medicine, Department of Surgery July 1999 – present
  • Educational Program Coordinator, Section of Plastic Surgery, Richard L. Roudebush Veterans Hospital, Indianapolis, IN August 1993 – 1999
  • Clinical Associate Professor of Surgery, Indiana University School of Medicine, Division of Plastic Surgery March 2004 – present

HOSPITAL AND OTHER APPOINTMENTS:

  • Indiana University Hospital, Indianapolis, IN, July 1993 – present
  • Surgical Director, Indiana University Cancer Center Melanoma Program 1994-2004
  • Richard L. Roudebush Veteran’s Hospital, Indianapolis, IN, July 1993 – present, Chief, Section of Plastic Surgery, 1993 – 1999
  • Wishard Memorial Hospital, Indianapolis, IN, July 1993 – 2008
  • James Whitcomb Riley Hospital for Children, Indianapolis, IN, August 1993 – 2008
  • Vencor Hospital of Indianapolis, Indianapolis, IN, October 1993 – 2003
  • Meridian Plastic Surgery Center, Indianapolis, IN, October 1993 – 2002
  • Clarian North Hospital, Indianapolis, IN, March 2005 – present
  • Community Hospitals of Indianapolis, IN, 2000 – present
  • Indiana Surgery Center, Indianapolis, IN, 2000 – present
  • Hamilton Surgery Center, Indianapolis, IN 2004 – present
  • St Vincent Hospital of Indianapolis, Indianapolis, IN 2004 – present
  • Fishers Surgery Center, Fishers, IN 2009 – present

OTHER APPOINTMENTS AND PROFESSIONAL CONSULTANTSHIPS:

  • Medical Director, Community Health Network Cutaneous Oncology Program
  • Medical Consultant, Villagio Day Spa

SPECIALTY BOARD STATUS:

  • Diplomate, National Board of Medical Examiners, 1987
  • Diplomate, American Board of Plastic Surgery, November 1995

LICENSURE AND CERTIFICATIONS:

  • National Board of Medical Examiners, Certificate #326579, July 1987
  • American Board of Plastic Surgery, Certificate # 1910, November 1995, recertified 2004
  • Indiana State Medical License, License #01041504

PROFESSIONAL ORGANIZATIONS:

  • American Medical Association, 1983 – present
  • Minnesota Medical Foundation, 1986 – present
  • Indianapolis Medical Society, 1993 – present
  • Indiana State Medical Association, 1993 – present
  • Association of VA Surgeons, 1993 – 1999
  • Plastic Surgery Educational Foundation, 1994 – present
  • Society of Head and Neck Surgeons, 1994 – 1998
  • Ohio Valley Society for Plastic and Reconstructive Surgery, 1994 – present
  • American Society of Plastic Surgeons, 1995 – present
  • Eastern Cooperative Oncology Group (Melanoma Committee), 1995 – 2008
  • Fellow, American College of Surgeon, 1996 – present
  • Indiana State Chapter, American College of Surgeons, 1993 – present
  • American Society of Clinical Oncology, 1996 – present
  • Society of Surgical Oncology, 1996 – present
  • Plastic Surgery Research Council, 1996 – present
  • American College of Surgeon Oncology Group, 1999 – present
  • Indiana Medical Oncology Society, 2000 – present
  • American Head and Neck Society, 1998 – present
  • ACOSOG Melanoma Committee Member
  • ACOSOG Audit Committee Member, 2001
  • ECOG Melanoma Committee Member (Surgery Liason), 2001 – 2004
  • Central Surgical Society, 2002 – present
  • American Association of Plastic Surgeons, May 2003 – present
  • American Society of Maxillofacial Surgeons 2003 – present
  • Australian Society of Plastic Surgeons (Honorary Member) 2005 – present
  • Americans Society of Bariatric Plastic Surgeons 2006 – present

HONORS AND AWARDS:

UNDERGRADUATE:
National Merit Scholarship Winner, 1978
Dean’s List
Magna Cum Laude, 1982

GRADUATE:
Alpha Omega Alpha, 1981
Outstanding Senior Medical Student Award, 1982

POSTGRADUATE / PROFESSIONAL:
Finalist, Decade Award, Gustavus Adolphus College
Department of Veterans Affairs Outstanding Rating Award, 1997
Strathmore’s WHO’S WHO award, 1998
International Directory of Distinguished Leadership, 2000
The Best Doctors in America Award, 1999 – 2010
America’s Top Surgeons Award, 2004 – 2010
Americans Top Plastic Surgeons 2006 – 2010

SERVICE ACTIVITIES

  • Eastern Cooperative Oncology Group Melanoma Committee, 1995 – present
  • Reed O. Dingman Society, Executive Committee, 1996 – present; Program Committee Chairman 2000 – 2002, President 2004 – 2007
  • Ohio Valley Society for Plastic and Reconstructive Surgery Scientific Committee Program, Co-Chair, 1998
  • American College of Surgeons Young Surgeon Representative, Indiana State Chapter, 1998
  • American Society for Plastic and Reconstructive Surgery, member of Head and Neck Subcommittee of the Scientific Program Committee, 1998
  • American College of Surgeons Indiana State Chapter Committee on Applicants, 2000 – 2002
  • Reviewer for professional journals: Annals of Surgical Oncology, Cancer, Journal of Surgical Oncology, Plastic and Reconstructive Surgery, Annals of Plastic Surgery, Journal of Pediatric Surgery, Journal of Clinical Oncology, Melanoma Research, Journal of Investigative Dermatology Editorial Board, Annals of Plastic Surgery 2004 – 2007
  • As Chairman of Cancer Committee, achieved approval of the Richard L. Roudebush VAMC Cancer Program by American College of Surgeons as a Teaching Hospital Cancer Program, and by Veterans Administration as a Comprehensive Cancer Center, 1997
  • Development and maintenance of computerized Melanoma Program Database, IU Cancer Center, 1997 – 2004
  • Plastic and Reconstructive Surgeon, Oncologic Surgeon
  • Chief, Section of Plastic Surgery, Richard L. Roudebush Veterans Medical Center, 1993 – 1999
  • Director, Tumor Board Conference, Richard L. Roudebush Veterans Medical Center, 1993 – 1999
  • Chairman, Cancer Committee, Richard L. Roudebush Veterans Medical Center, 1994 – 1999
  • Surgical Director, IU Cancer Center Interdisciplinary Melanoma Program, 1994 – present
  • Pharmacy and Therapeutic Committee, Richard L. Roudebush Veterans Medical Center, 1994 – 1999
  • Ad Hoc Search and Screen Committee for Chief of Medicine, Richard L. Roudebush Veterans Medical Center, 1994
  • Indiana University Cancer Center Scientific Review Committee, 1995 – present
  • Ad Hoc Tissue Review Committee, Indiana University Medical Center, September 1996 – present
  • Ad Hoc Basic Science Curriculum Committee, Department of Surgery, 1996
  • Indiana University Cancer Center Operations Committee, 1997 – present
  • VA Medical Center Cancer Committee, 1997 – 1999
  • IU Cancer Center Adult Oncology Program, Melanoma-Sarcoma Group, Leader, 1998 – present
  • Ad Hoc Internal Proposals for Restricted Competitions Committee, Indiana University Medical Center, 1997-2003
  • Clarian Cancer Committee, Clarian Health, July 1999 – 2004
  • Indiana Surgery Center Operations/Advisory Committee, 2006 – present
  • Cancer Committee, Community Health Network, Indianapolis 2005 – present
  • Director Cutaneous Oncology Program, Indiana Community Health Network, 2004 – present

PUBLICATIONS

REFEREED JOURNALS:

* work at Indiana University

1. Wagner JD, Stahler C, Knox S, et al: The Clinical Utility of Open Lung Biopsy for Undiagnosed Pulmonary Infiltrates. American Journal of Surgery; Vol. 164 (2), 104-107, 1992

2. Wagner J, Cohen S, Maher H, Dauser R, Newman MH: Critical Analysis of Results of Surgery for Bicoronal Synostosis. The Journal of Craniofacial Surgery, 6:27-32, 1994

3. Cohen SR, Maher H, Wagner J, Dauser R, Newman M: Metopic Stenosis: Evaluation of Aesthetic Results. Plastic and Reconstructive Surgery, 94:759-767, 1994

4. Wagner JD and Newman MH: Bipedicled Cross-Lip Flap for Correction of Major Vermilion Deficiency After Cleft Lip Repair. The Cleft Palate – Craniofacial Journal, 31:148, 1994

5. Wagner J, Cohen S, Maher H, Dauser R, Newman MH: Critical Analysis of Results of Craniofacial Surgery for Nonsyndromic Bicoronal Synostosis. The Journal of Craniofacial Surgery, Vol. 6, No 1:32-37, 1995

6.* Wagner JD and Prevel CD: Histoplasma Capsulatum Necrotizing Myofasciitis of the Upper Extremity. Annals of Plastic Surgery; Vol. 6(3):330-333, 1996

7.* Wagner JD, Ress A, Coleman JJ: Repair of Midline Vertical Lower Lip Deficiency After Mandible Reconstruction. The American Journal of Surgery, 172:625-627, 1996

8.* Williams J, Carlson G, Howell R, Wagner J, Nahai F, Coleman J: The Tensor Fascia Lata Free Flap in Abdominal-Wall Reconstruction. Journal of Reconstructive Microsurgery, Vol. 13 No 2:83-91, 1997

9.* Wagner JD, Coleman JJ, Schauwecker D, Hutchins G: Initial Assessment of Positron Emission Tomography for Detection of Nonpalpable Regional Lymphatic Metastases in Melanoma. Journal of Surgical Oncology, 64:181-189, 1997

10.* Wagner JD, Righi P, Coleman JJ: Metastatic Melanoma to Retropharyngeal Lymph Nodes Causing Pharyngeal Obstruction. Annals of Plastic Surgery, 40:84-87, 1998

11.* Righi P, Wagner J, Anderson P: Odontogenic Keratocyst of the Mandible: Surgical Management and Reconstruction. Annals of Plastic Surgery, 41:89-93, 1998

12.* Wagner J, Coleman JJ, Weisberger E, Righi P, Radpour S, McGarvey S, Bayler A, Chen J, Crow H. Predictive Factors for Functional Recovery after Free Tissue Transfer Oromandibular Reconstruction. American Journal of Surgery, 176:430-435, 1998

13.* Wagner J, Havlik R. Upper Lip Flap for Restoration of Nasal Lining in Full Thickness Nasal Defects. Letter-to-the-editor, Annals of Plastic Surgery, 42;109-110, 1999

14.* Wagner J, Davidson D, Coleman J, Hutchins G, Schauwecker D, Park HM, Havlik R. Lymph Node Tumor Volumes in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Melanoma. Annals of Surgical Oncology, 6(4):398-404, 1999

15.* Sian K, Wagner J, Sood R, Park HM, Havlik R, Coleman J. Lymphoscintigraphy with Sentinel Lymph Node Biopsy in Cutaneous Merkel Cell Carcinoma. Annals of Plastic Surgery, 42(6);679-682, 1999

16.* Sian K, Havlik R, Binford R, Broadie T, Wagner J. Breast Cancer In Poland Syndrome. Plastic and Reconstructive Surgery, 104(1):180-182, 1999

17.* Wagner J, Schauwecker D, Davidson D, Coleman J, Saxman S, Hutchins G, Love C. Prospective Study of FDG-PET Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node Biopsy. Journal of Clinical Oncology, 17:1508-1515, 1999

18.* Golosow L, Wagner JD, Feeley M, Sharp T, Havlik R, Sood R, Coleman JJ. Risk Factors for Predicting Surgical Salvage of Sternal Wound Healing Complications. Annals of Plastic Surgery, 43(1):30-35, 1999

19.* Wagner JD, Gordon MS, Chuang TY, Coleman JJ. Current Therapy of Cutaneous Melanoma, Plastic and Reconstructive Surgery, 105:1774, 2000

20.* Wagner J, Coleman J, Park H, Love C, Hayes JL. Cervical Sentinel Lymph Node Biopsy (SNB) for Melanomas of the Head and Neck and Upper Thorax. Archives of Surgery,1999. Arch Otolaryngol Head Neck Surgery, 126:313-321, 2000

21.* Wagner J, Corbett L, Park HM, Davison D, Coleman JJ, Havlik R, Hayes JT. Sentinel Lymph Node Biopsy for Melanoma: Experience with 234 Consecutive Procedures. Plastic and Reconstructive Surgery, 105:1956, 2000

22.* Wagner JD, Gordon MS, Chuang TY, Coleman JJ, Jung SH, Love C. Predicting Sentinel Lymph Node Metastases and Residual Nodal Disease After Sentinel Node Biopsy for Melanoma. Cancer, 89:453-62, 2000

23.* Wagner JD. (Brief Communication) Management of the Residual Lymph Node Basin after Sentinel Lymph Node Biopsy for Melanoma written by Pu, Cruse, Wells, et al. published in Plastic and Reconstructive Surgery, Volume 104 pages 964-969, 1999

24.* Wagner J. Management of Malignant Melanoma: Current Techniques and Controversies, 69th Annual ASPS/PSEF/ASMS Scientific Meeting, October 14-18, 2000 (Video Tape Publication)

25.* Wagner JD, Schauwecker DS, Davidson D., Wenck S., Jung SH., Hutchins, G. FDG-PET Sensitivity for Melanoma Lymph Node Metastases Is Dependent on Tumor Volume. Journal of Surgical Oncology, 2001 Aug; 77 (4):237-242

26.* Chuang, TY, Brashear, R., Wagner, JD., Framer, E. Principles of Evidence-Based Management using Stage I-II Melanoma as a Model. International Journal of Dermatology 2002, Nov; 41, (11): 721-728

27.* Wagner JD, FDG-PET Imaging for Nodal Metastates in Melanoma. The Melanoma Letter, Volume 20, Number 2, 2002

28.* Wagner JD, Ranieri J, Evdokimow D, Logan T, Chuang TY, Johnson CS, Wenck S, Coleman JJIII. Patterns of Initial recurrence and prognosis after sentinel node biopsy and selective lymphadenectomy for melanoma. Plastic and Reconstructive Surgery, 2003, 112(2): 486-497

29.* Ranieri, J, Wagner JD, Azule R, Wenck S, Fyffe J, Davidson D, Coleman, JJ. Prognostic Importance of Lymph Node Tumor Burden in Melanoma Patients Staged by Sentinel Node Biopsy. Annals of Surgical Oncology, 2002, Dec. 9 (10): 975-981

30.* Edokimow D, Wagner JD, Bhuller A, Coleman JJ, Moore D, Wenck S. Lymphatic Mapping and Sentinel Node Biopsy for High Risk Cutaneous Carcinomas. Archives of Dermatology (In review)

31.* Toro, J, Ranieri, JM, Havlik, R, Wagner, JD, “Sentinel Lymph Node Biopsy in Pediatric and Adolescent Malignant Melanoma”. Journal of Pediatric Surgery 2003; 38(7):1063-65

32.* Schauwecker DS, Siddiquis AR, Wagner JD, Davidson D, Jung S-H, Carlson KA, Hutchins GD. Melanoma patients evaluated by four different PET reconstruction techniques. Nuclear Medicine Communications, 2003; 24 (3): 281-289

33.* Wagner JD. PET Detection of Melanoma Metastases in Lymph Nodes. Journal of Nuclear Medicine, 2003; 44 (3): 486

34.* Wagner JD, Sondak VK. The Sentinel Lymph Node: More Than Just Another Blue Lymph Node. Cancer, 2003, April, 97 (8): 1821-1823

35. Wagner JD, Bergman D. Primary Cutaneous Melanoma: Surgical Management and other Treatment Options. Current Treatment Opinions in Oncology. 2003; 4(3):177-85

36. Van Aalst, J., Wagner, JD., FDG-PET Imaging For Staging Of Patients With Melanoma, Transworld Research Network, Recent Res. Devel. Cancer, 4, 2002, 527-540

37. Wagner, JD. A role for FDG-PET in the surgical management of stage IV melanoma. Ann Surg Oncol 2004; 11(8):721-2

38. Wagner JD, Schauwecker DS, Hutchins G, Coleman JJ III, Davidson DD, Logan T. Inefficacy of FDG PET in the Initial Staging of Patients with Melanoma. Cancer 2005; 104: 570-579

39. Wagner, JD. Sentinel Node Biopsy in cutaneous melanoma: analysis of 240 consecutive cases. Invited Discussion. Plastic and Reconstructive Surgery 2005; 115 (7): 1952-3

40. Ranieri J, Wagner JD, Wenck SD, Calley C. Prognostic importance of sentinel node status in thin cutaneous melanoma. Annals of Surgical Oncology 2006;13(7): 927-32

41. Ranieri J, Wagner JD, Wiebke, EG, Wenck SD, Smith M. RT-PCR for tyrosinase messenger RNA does not predict outcome in melanoma. Plastic and Reconstuctive Surgery, Plastic and Reconstructive Surgery, 2005; 115 (4):1058-63.

42. Wu YH, Kim GH, Wagner JD, Hood A, Chuang, TY. The association between malignant melanoma and non-cutaneous malignancies. Int J Dermatol, 2006 45 (5): 529-34

43. Wagner, JD. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications. Ann Surg Oncl 2006; 13 (4):444-6.

44. Wagner, JD. Sentinel node biopsy in cutaneous melanoma: analysis of 240 consecutive cases (discussion/editorial). Plast Reconstr Surg 2005 115 (7):1952-53.

PUBLISHED ABSTRACTS:

* work at Indiana University

1. Wagner JD, Stahler C, Knox S, et al. Clinical Utility of Open Lung Biopsy for Undiagnosed Pulmonary Infiltrates. Respiratory Diseases Digest, Vol. 3, pages 6-7, 1993.

2. Wagner J, Newman MH. Bipedicled Cross Lip Flap for Correction of Major Vermilion Deficiency After Cleft Lip Repair. Abstract Proceedings for the Plastic Surgery Senior Residents Meeting, San Diego, California, May 1993.

3. Wagner J, Gitt S, and Wilkins E. Immediate Free TRAM Flap Reconstruction. Abstract Proceedings for the Plastic Surgery Senior Residents Meeting, San Diego, California, May 1993.

4.* Williams J, Carlson J, Wagner J, Coleman JJ. Abdominal Wall Reconstruction Using Free Tensor Fascia Lata Transfer. Abstract Proceedings for the Society of Reconstructive Microsurgery Meeting, Singapore, February 1995.

5.* Wagner JD, Coleman JJ, Schauwecker D. Positron Emission Tomography for Detection of Subclinical Lymph Node Metastases in Malignant Melanoma. Scientific Program for the 38th Ohio Valley Society for Plastic and Reconstructive Surgery Meeting, Cleveland, Ohio, June 1994.

6.* Mount DL, Wagner JD, Coleman JJ. Effects of Radiation Therapy on Osteomyocutaneous Free Flap Oromandibular Reconstruction. Scientific Program for the 38th Ohio Valley Society for Plastic and Reconstructive Surgery Meeting, Cleveland, Ohio, June 1995.

7.* Elleru R, Wagner, JD, Prevel, C. Histoplasma Capsulatum Necrotizing Myofasciitis: Case Report, Scientific Program for the 38th Ohio Valley Society for Plastic and Reconstructive Surgery Meeting, Cleveland, Ohio, June 1995.

8.* Mount DL, Wagner JD, Coleman JJ. Impact of Intraoperative Frozen Section Margin Analysis on Immediate Oromandibular Free Flap Reconstruction. Scientific Program for the First Conjoint Symposium on Contemporary Head and Neck Reconstruction Meeting, July 1995.

9.* Wagner JD. Assessment of Positron Emission Tomography for Detection of Subclinical Regional Lymph Node Metastases in Melanoma. Abstract 92. Page 28. Abstract Book for the 49th Annual Cancer Symposium Society of Surgical Oncology Meeting, Atlanta, Georgia, March 24, 1996.

10.* Wagner JD, Schauwecker D, Hutchins G, Coleman JJ. Positron Emission Tomography for Detection of Occult Regional Lymph Node Metastases in Melanoma. Abstract #1349, page 435. Program/Proceedings for the American Society of Clinical Oncology 32nd Annual Meeting. Philadelphia, Pennsylvania, May 21, 1996.

11.* Wagner JD, Schauwecker D, Hutchins G, Coleman JJ. Positron Emission Tomography for Detection of Occult Regional Lymph Node Metastases in Melanoma. Abstract Program for the Plastic Surgery Research Council 41st Annual Meeting, Meeting, June 4, 1996.

12.* Wagner JD, Schauwecker D, Hutchins G, Coleman JJ. Positron Emission Tomography for Detection of Occult Regional Lymph Node Metastases in Melanoma.Scientific Program for the 39th Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Cleveland, Ohio, June 8, 1996.

13.* Wagner JD, Schauwecker D, Hutchins G, Coleman JJ. Positron Emission Tomography Detection of Occult Regional Lymph Node Metastases in Melanoma. Abstract #426. Plastic Surgical Forum ASPRS/PSEF/ASMS 65th Annual Scientific Meeting, Dallas, Texas, November 13, 1996.

14.* Mount D, Sood R, Wagner J, Coleman J. Outcome of Simultaneous Repair of Bilateral Decubitus Ulcers. Scientific Program for the 39th Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Cleveland, Ohio, June 8, 1996.

15.* Frank R, Wagner J, Coleman J. Isolation Limb Perfusion: The Indiana University Experience. Scientific Program for the 39th Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Cleveland, Ohio, June 8, 1996.

16.* Ress A, Wagner J, Coleman J. Lower Lip Repair After Mandibular Reconstruction. Scientific Program of the 39th Annual Meeting for the Ohio Valley Society for Plastic and Reconstructive Surgery, Cleveland, Ohio, June 8, 1996.

17.* Golosow L, Wagner J, Feeley M, Sharp T, Sood R, Sadove M, Havlik R, Eppley B, Coleman J. Management of Sternal Wound Complications: A Review of Primary Closure Versus Muscle Flap Reconstruction. Abstract #12. Scientific Program for the 40th Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Indianapolis, Indiana, June 6, 1997.

18.* Wagner J, Park HM, Davidson D, Schauwecker D, Coleman JJ. Sentinel Lymph Node Biopsy for Cutaneous Melanoma. Proceedings for the Indiana University School of Medicine Scientific Session, Platform 2, Indianapolis, Indiana, January 30, 1998.

19.* Wagner J, Davidson D, Hutchins D, Schauwecker J, Coleman JJ. Lymph Node Tumor Volumes in Patients Undergoing Sentinel Lymph Node Biopsy for Melanoma. Abstract #50. The Society of Surgical Oncology 49th Annual Cancer Symposium Abstract Book, San Diego, California, March 26-29, 1998.

20.* Wagner J, Coleman J, Weisberger E, Righi P. Predictive Factors for Functional Recovery After Free Tissue Transfer Oromandibular Reconstruction. Scientific Program for the 1998 Combined Meeting Program for the American Society for Head and Neck Surgery and Society of Head and Neck Surgeons, Page 50-51., Palm Beach, Florida, May 14-16, 1998.

21.* Wagner J, Coleman JJ, Hutchins G, Schauwecker D, Davidson D. A Prospective Study of FDG-PET Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Lymph Node Biopsy. Abstract #1986, page 515a. Program/Proceedings for the American Society of Clinical Oncology 34th Annual Meeting, Los Angeles, California, May 16-19, 1998.

22.* Corbett L, Wagner J, Coleman JJ, Hutchins G, Schauwecker D, Davidson D. Lymphatic Mapping and Sentinel Node Biopsy for Clinically Localized Melanoma: Experience in 115 Patients. Abstract #1953, page 507a. Program/Proceedings for the American Society of Clinical Oncology 34th Annual Meeting, Los Angeles, California, May 16-19, 1998.

23.* Park HM, Wagner J. Dermolymphoscintigraphy (LS) in 115 Patients with Cutaneous Melanoma: Technical Considerations and Correlation with Sentinel Node (SN) Biopsy Results. Abstract #90. Journal of Nuclear Medicine Supplement Vol. 39 (5). Scientific Abstracts for the 45th Annual Meeting of the Society of Nuclear Medicine. Toronto, Canada, June 7-11, 1998.

24.* Wagner J, Coleman JJ, Weisberger E, Righi P, Radpour S, McGarvey S, Bayler A, Chen J, Crow H, Havlik R. Functional Recovery after Microvascular Oromandibular Reconstruction. Abstract #22. Scientific Program for the 41st Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Farmington, Pennsylvania, June 11-14, 1998.

25.* Sian K, Wagner J, Sood R, Park H, Havlik R, Coleman J. Lymphoscintigraphy with Sentinel Lymph Node Biopsy in Cutaneous Merkel Cell Carcinoma. Abstract #23. Scientific Program for the 41st Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Farmington, Pennsylvania, June 11-14, 1998.

26.* Wagner J, Coleman JJ, Hutchins G, Schauwecker D, Davidson D. Lymphatic Mapping and Sentinel Node Biopsy for Clinically Localized Melanoma: Experience in 160 Patients. Abstract #24. Scientific Program for the 41st Annual Meeting of the Ohio Valley Society for Plastic and Reconstructive Surgery, Farmington, Pennsylvania, June 11-14, 1998.

27.* Wagner J, Coleman J, Park H, Overley C, Hayes JL. Cervical Sentinel Lymph Node Biopsy (SNB) for Melanomas of the Head and Neck and Upper Thorax. Abstract #64, page #47. Scientific Program for the Annual American Head and Neck Society Meeting, Palm Desert, California, April 24-27, 1999.

28.* Wagner J, Park HM, Hayes J, Coleman JJ. Sentinel Lymph Node Biopsy and Selective Lymphadenectomy for Cutaneous Melanoma: Selection Recommendations Based on Experience with 234 Consecutive Procedures. Page 74-75. Scientific Program for the 78th Annual Meeting of the American Association of Plastic Surgeons, Colorado Springs, CO, May 2-5, 1999.

29.* Wagner J, Corbett L, Park MD, Coleman JJ, Overley C, Hayes JL. Patient Selection for Sentinel Node Biopsy: Prediction of Sentinel and Nonsentinel Lymph Node Metastases by Primary Melanoma Tumor Characteristics. Abstract # 2041, page #529a. Program/Proceedings for the American Society of Clinical Oncology 35th Annual Meeting, Atlanta, GA, May 15-18, 1999.

30.* Wagner J, Aguiar J, Wiebke E. Peripheral Blood (PB) PCRTYR Does Not Correlate with Clinical Disease Status or Stage in Patients with Malignant Melanoma. Abstract #56B, page #224. Program/Proceedings for the 44th annual meeting of the Plastic Surgery Research Council, Pittsburgh, Pennsylvania, May 22-25, 1999 (Poster Presentation).

31.* Wagner J, Schauwecker D, Davidson D, Gordon M, Coleman JJ, Hutchins G, Wenck S. Initial FDG-PET Staging in Clinical Stage I Melanoma: An Insensitive Screen for Metastases. Abstract #2239, page 568a. Program/Proceedings for the American Society of Clinical Oncology 36th Annual Meeting, New Orleans, Louisiana, May 20-23, 2000.

32.* Wagner J, Schauwecker D, Davidson D, Wenck S, Jung S. Threshold for FDG-PET Detection of Melanoma Nodal Metastases. Melanoma at the Millennium Symposium, Phoenix, Arizona, February 16-19, 2000

33.* Wagner J, Evdokimow D, Coleman JJ, Wenck S, Jung SH. Patterns of Initial Recurrence and Prognosis After Sentinel Node Biopsy and Selective Lymphadenectomy for Melanoma. Abstract 209, page 363-364. ASPRS/PSEF/ASMS 69th Annual Scientific Meeting, Los Angeles, California, October 14-18, 2000.

34.* Ranieri J, Wagner JD, Azule R, Wenck S, Fyffe J, Davidson D, Coleman JJ. Prognostic Important of Lymph Node Tumor Burden in Melanoma Patients Staged by Sentinel Node Biopsy. Annals of Surgical Oncology, 9:S79, (abstract P132), 2002

35.* Schwauwecker DS, Siddiqui AS, Wagner JD, Davidson D, Jung S-H, Carlson KA, Hutchins GD. 119 melanoma patients evaluated with four different PET reconstruction techniques. Radiology; 217:359-360, 2000

36.* Wagner JD, Schwauwecker DS, Davidson D, Logan T, Hutchins GD, Jung S-H, Wenck S, Coleman JJ. Inefficiency of FDG-PET for the Initial Staging of Clinical Stage I Cutaneous Melanoma. Melanoma Research, Volume 11, Supplement 1: S213, February 2001.

BOOK CHAPTERS

1. Benign and Malignant Head and Neck Tumors, chapter in Plastic Surgery: A Core Curriculum, Wagner JD, Rees, RS. Mosby Yearbook, St. Louis, 1994. Ruberg R and Smith DJ, eds.

2. Penetrating Facial Trauma, chapter in Textbook of Penetrating Trauma, Wagner JD, Smith DJ. Lea and Febiger, 1995. Ivatury I and Cayten G, eds.

3. Scapular System Free Flaps for Head and Neck Reconstruction, chapter in Reconstructive Plastic Surgery, Wagner JD and Coleman JJ. Mosby Yearbook, St. Louis, 1996:107-129, Kroll S, ed.

4. Preoperative Assessment and Preparation for Mandible Reconstruction, chapter in Operative Techniques in Plastic and Reconstructive Surgery, Wagner JD. W.B. Saunders Co., Philadelphia, Vol. 3, No 4; 1996:217-225. Jurkiewicz MJ, Culbertson JH, Coleman JJ, eds.

5.* Salvary Gland Disorders, in Plastic Surgery: Indications, Operations, Outcomes. Wagner JD, Coleman JJ. Mosby Yearbook, St. Louis; 2000: Vol. 3. Achauer B, Achauer BM, Eriksson E, Guyuron B. Russell RC, Vanderkolk CA, eds. Pp 1355-1395.

6.* Role of Positron Emission Tomography for Early Detection of Nonpalpable Regional Lymphatic Metastases in Melanoma, chapter in Malignant Melanoma. Diagnosis and Treatment. Wagner JD. Nicola TF, ed.

7.* Mandible Reconstruction with the Fibula Free Flap, chapter 78 in Plastic Surgery: Indications, Operations, and Outcomes Mantooth G, Wagner JD. Mosby Yearbook, St. Louis; 2000. Achauer, Eriksson, Guyuron, Coleman JJ, Russell, Vanderkolk, eds. Pp. 1279-1287.

8.* Nahabedian M, Wagner JD. Complex closures of melanoma excisions. In Cutaneous Melanoma 4th ed. Balch, ed. 2003, St. Louis, Quality Medical Publishing. Pp. 231-262.

9.* Van Aalst J., McCurry T., Wagner, JD. Reconstructive Considerations In The Surgical Management Of Melanoma, Surgical Clinics of North America, Feb. 2003, 83:1 187-230.

10.* Grasee, E., Wagner, JD., Update On Diagnostic Imaging for Melanoma, Facial Plastic Surgery Clinics of North America, Feb. 2003, 11:1, 49-60.

TEACHING AND SERVICE-RELATED PUBLICATIONS

1.* Wagner J: Lymph Node Dissections in Malignant Melanoma: Who Is A Candidate? Clinical Care Update for Indiana University Cancer Center Outlook Magazine, 1995.

2.* Saxman S, Wagner JD: Recent Advances in the Treatment of Malignant Melanoma. Outlook Magazine, June 1996.

3.* Chuang TY, Wagner JD: Melanoma and Other Skin Cancers, Primarily Medicine. A Video Medical Journal, Vol. 1, No. 2, segment 3, 1997.

4.* Wagner JD: Study Suggests Management Could Stop at SLN Biopsy for Some Melanoma Patients. Oncology News International, February, 2000.

5.* Wagner JD, Current Techniques and Controversies in Melanoma. Videotape, Plastic Surgery Education Foundation, 2002.

GRANTS, CONTRACTS AND FELLOWSHIPS

LABORATORY

1. Principle Investigator, Protocol 9511-09: Reverse Transcriptase Polymerase Chain Reaction Detection of Circulating Tyrosinase mRNA in Patients with Melanoma. Supported by Plastic Surgery Educational Foundation Research Grant ($5,000 direct funds) 6/96 – 6/98.

2. Principle Investigator, Protocol 9904-08: New Approaches in Melanoma Staging. Supported by Pence Foundation Grant, 1998 – 2002 ($140,000 total funds)

CLINICAL

1. Principle Investigator, Protocol 9406-36: Efficacy of PET Scans for Subclinical Regional Lymphatic Metastases in Patients with Malignant Melanoma. Supported by American Cancer Society Institutional (Grant# IRG-161, $9,000 direct funds) 7/1/94 – 6/30/95.

2. Principle Investigator, Protocol 9412-22: Open Label Pharmacokinetic Study of Dibutyryl Cyclic AMP Ointment (DT-5621) in the Treatment of Stage III Pressure Ulcers. Supported by Diaiichi Pharmaceutical Company ($33,000 total funds) 1/1/95 – 9/30/96.

3. Principle Investigator, Protocol 9410-22: A Multicenter Evaluator Blinded Three Arm Study of Safety and Efficacy of Bucladesine Sodium Ointment (DT-5621) in the Treatment of Stage III Pressure Ulcers in Spinal Cord Injury Patients. Supported by Diaiichi Pharmaceutical Company ($129,000 total funds) 10/1/95 – 9/29/97.

4. Principle Investigator, Protocol 9501-23: Functional Assessment of Immediate Oromandibular Reconstruction. Supported by Plastic Surgery Educational Foundation Research Grant ($5,000 direct funds) 7/1/95 – 6/30/98.

5. Principle Investigator, Protocol 9603-18: PET Imaging in the Surgical Management of Melanoma. Supported by National Institutes of Health (Grant #R01 CA74389-01, $788,575 total funds) 6/1/97 – 3/31/01.

6. Principle Investigator, Protocol 9805-32: A Phase III Randomized Double-Blind Trial of Immunotherapy with a Polyvalent Melanoma Vaccine (C-VAX) plus BCG versus Placebo plus BCG as a Post-Surgical Treatment for Stage IV Melanoma. Sponsored by John Wayne Cancer Institute, JWCI-MC-4-001 ($150,950 total funds) NIH ROICA 76489-01A1, 6/1/98 – 4/30/03.

7. Principle Investigator, Protocol 9908-20: A Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy with BCG plus a Polyvalent Melanoma Vaccine, Cancer Vax versus BCG plus a Placebo as a Post-Surgical Treatment for Stage III Melanoma. Sponsored by John Wayne Cancer Institute, JWCI-MC-3-001 ($374,100 total funds) NIH 5POICA12582-29, 2/1/99 – 1/31/03.

8. Principle Investigtor: Wide versus Narrow excision plus Selective Lymphadnectomy in Patients with Cutaneous Melanoma greater than 2.0 mm Breslow thickness. Proposed Multicenter Randomized Trail; American College of Surgeons Oncology Group, Study Z0280. Developmental funds ($8,000 total funds) NIH R02CAPP-01, 5/1/01 – 4/30/02.

Dr. Wagner also has an extensive list of publications, published abstracts, book chapters, and laboratory and clinical grants. If you would like to learn more about any of these, please ask for a complete copy of his curriculum vitae when you come to Wagner and Associates Plastic and Reconstructive Surgery Consultants for your consultation.